Oncology News

Oncology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kondo T et al. - The data suggest that epigenetics is involved with inactivation of TTF-1 in thyroid carcinomas, and provide a possible means of using TTF-1 as a target for differentiation-inducing therapy through epigenetic modification.

Related Articles

Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: Report of a case
Surgery Today, 10/06/09    Relevance Score: 69%

S100A8 and S100A9 Expression Is a Crucial Factor for Dedifferentiation in Thyroid Carcinoma
Anticancer Research, 11/11/09    Relevance Score: 68%

Diffuse Sclerosing Variant Is a Major Subtype of Papillary Thyroid Carcinoma in the Young
Thyroid, 11/06/09    Relevance Score: 68%

A Proposal for a Thyroid Imaging Reporting and Data System for Ultrasound Features of Thyroid Carcinoma
Thyroid, 10/12/09    Relevance Score: 68%

Thyroid Ultrasonography
World Journal of Surgery, 10/20/09    Relevance Score: 67%